ENVERIC BIOSCIENCES, INC. Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
ENVERIC BIOSCIENCES, INC. (ENVB) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent of -$6.86 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 · last filed 2021-04-01
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2020-12-31 was -$2.21M, a 321.07% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2020-09-30 was -$1.06M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2020-06-30 was -$1.67M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2020-03-31 was -$1.93M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2020 was -$6.86M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2019 was -$2.41M.
- ENVERIC BIOSCIENCES, INC. other comprehensive income (loss), tax, portion attributable to parent for fiscal 2018 was -$19.43M.
| Period end | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01 | -$3.27M derived: sum of 2 quarters · filed 2021-04-01 | -$4.94M derived: sum of 3 quarters · filed 2021-04-01 | -$6.86M 10-K · filed 2021-04-01 | |
| 2020-09-30 | -$1.06M 10-Q · filed 2020-11-16 | -$2.72M derived: sum of 2 quarters · filed 2020-11-16 | -$4.65M 10-Q · filed 2020-11-16 | -$3.65M derived: sum of 4 quarters · filed 2021-04-01 | |
| 2020-06-30 | -$1.67M 10-Q · filed 2020-08-14 | -$3.59M 10-Q · filed 2020-08-14 | -$2.59M derived: sum of 3 quarters · filed 2021-04-01 | -$2.68M derived: sum of 4 quarters · filed 2021-04-01 | |
| 2020-03-31 | -$1.93M derived: 10-K 12 month − 3 quarters · filed 2021-04-01 | -$927.19K derived: sum of 2 quarters · filed 2021-04-01 | -$1.01M derived: sum of 3 quarters · filed 2021-04-01 | -$2.39M derived: sum of 4 quarters · filed 2021-04-01 | |
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01 | $917.23K derived: sum of 2 quarters · filed 2021-04-01 | -$463.71K derived: sum of 3 quarters · filed 2021-04-01 | -$2.41M 10-K · filed 2021-04-01 | -$6.06M 10-K/A · filed 2020-08-12 |
| 2019-09-30 | -$83.44K 10-Q · filed 2020-11-16 | -$1.46M derived: sum of 2 quarters · filed 2020-11-16 | -$3.41M 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | -$1.38M 10-Q · filed 2020-08-14 | -$3.33M 10-Q · filed 2020-08-14 | |||
| 2018-12-31 | -$19.43M 10-K/A · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |